Zn-ion Batteries: Charge Storing Mechanism and Development Challenges.

Improving the energy share of renewable energy technologies is the only solution to reduce greenhouse gas emissions and air pollution. The high-performing green battery energy storage technologies are critical for storing energy to address the intermittent nature of renewable energy resources. In recent years, aqueous batteries, particularly Zn-ion batteries (ZIBs), have achieved and shown great potential for stationary energy storage systems owing to their low cost and safer operation. However, the practical applications of the ZIBs have significantly been impeded due to the gap between the breakthroughs achieved in academic research and industrial developments. The present review discusses the ZIB's advantages, possibilities, and shortcomings for stationary energy storage systems. The Review begins with a brief introduction to the ZIBs and their charge storage mechanisms based on the structural properties of cathode materials. The scientific and technical challenges that obstruct the commercialization of the ZIBs are discussed in detail concerning their impact on accelerating the utilization of the ZIBs for real-life applications. The final section highlights the outlook on research in this flourishing field.

Fluorine Engineered Self-Supported Ultrathin 2D Nickel Hydroxide Nanosheets as Highly Robust and Stable Bifunctional Electrocatalysts for Oxygen Evolution and Urea Oxidation Reactions.

Developing highly efficient noble-metal-free electrocatalysts with a scalable and environmentally friendly synthesis approach remains a challenge in the field of electrocatalytic water splitting. To overcome this problem, self-supported fluorine-modified 2D ultrathin nickel hydroxide (F-Ni(OH)2 ) nanosheets (NSs) for the oxygen evolution reaction (OER) and urea oxidation reaction (UOR) are prepared with a scalable and ascendant one-step synthesis route. The enhanced redox activity, electrical conductivity and a great number of exposed active sites of the heterogeneous catalysts improve charge migration for the electrocatalytic reactions. The density of states of the d orbitals of the Ni atoms significantly increases near the Fermi level, thereby indicating that the Ni atoms near the F-dopants promote electrical conduction in the Ni(OH)2 monolayer. The F-Ni(OH)2 electrocatalyst exhibits notable OER and UOR activity with onset potentials of 1.43 and 1.16 V versus RHE, respectively required to reach 10 mA cm-2 , which are comparable to those of commercial noble-metal-based electrocatalysts. With RuCo-OH nanospheres, the settled F-Ni(OH)2 ||RuCo-OH cell requires merely 1.55 and 1.37 V to reach 10 mA cm-2 with superb durability for 24 h in overall water and urea electrolysis, respectively. Overall, high-quality, and efficient noble-metal-free electrocatalysts for overall water and urea electrolysis can be prepared with a simple, scalable, and reproducible preparation method.

Folate-conjugated nanovehicles: Strategies for cancer therapy.

Cancer theranostics represents a strategy that aims at combining diagnosis with therapy through the simultaneous imaging and targeted delivery of therapeutics to cancer cells. Recently, the folate receptor alpha has emerged as an attractive theranostic target due to its overexpression in multiple solid tumors and its great functional versatility. In fact, it can be incorporated into folate-conjugated nano-systems for imaging and drug delivery. Hence, it can be used along the line of personalized clinical strategies as both an imaging tool and a delivery method ensuring the selective transport of treatments to tumor cells, thus highlighting its theranostic qualities. In this review, we will explore these theranostic characteristics in detail and assess their clinical potential. We will also discuss the technological advances that have allowed the design of sophisticated folate-based nanocarriers harboring various chemical properties and suited for the transport of various therapeutic agents.

Two-Dimensional Materials for High-Energy Solid-State Asymmetric Pseudocapacitors with High Mass Loadings.

A porous nanostructure and high mass loading are crucial for a pseudocapacitor to achieve a good electrochemical performance. Although pseudocapacitive materials, such as MnO2 and MoS2 , with record capacitances close to their theoretical values have been realized, the achieved capacitances are possible only when the electrode mass loading is less than 1 mg cm-2 . Increasing the mass loading affects the capacitance as electron conduction and ion diffusion become sluggish. Achieving fast ion and electron transport at high mass loadings through all active sites remains a challenge for high-mass-loading electrodes. In this study, 2D MnO2 nanosheets supported on carbon fibers (MnO2 @CF) as well as MoS2 @CF with high mass loadings (6.6 and 7.2 mg cm-2 , respectively) were used in a high-energy pseudocapacitor. These hierarchical 2D nanosheets yielded outstanding areal capacitances of 1187 and 495 mF cm-2 at high current densities with excellent cycling stabilities. A pliable pseudocapacitive solid-state asymmetric supercapacitor was designed using MnO2 @CF and MoS2 @CF as the positive and negative electrodes, respectively, with a high mass loading of 14.2 mg cm-2 . The assembled solid-state asymmetric cell had an energy density of 2.305 mWh cm-3 at a power density of 50 mW cm-3 and a capacitance retention of 92.25 % over 11 000 cycles and a very small diffusion resistance (1.72â€…Ω s-1/2 ). Thus, it is superior to most state-of-the-art reported pseudocapacitors. The rationally designed nanostructured electrodes with high mass loading are likely to open up new opportunities for the development of a supercapacitor device capable of supplying higher energy and power.

Folate-targeted immunotherapies: Passive and active strategies for cancer.

The glycoprotein FRα is a membrane-attached transport protein that is shielded from the immune system in healthy cells. However, it is upregulated in various malignancies, involved in cancer development and is also immunogenic. Furthermore, FRα is a tumor-associated antigen endowed with unique properties, thus rendering it a suitable target for immunotherapeutic development in cancer. Various anti- FRα immunotherapeutic strategies are thus currently being developed and clinically assessed for the treatment of various solid tumors. These approaches include passive anti-FRα immunotherapies, such as monoclonal antibodies, or active immunotherapies, such as CART, folate haptens and vaccines. In this review, we will explore the advances in the field of FRα-based immune therapies and discuss both their successes and shortcomings in the clinical setting.